Pharmacokinetic and pharmacodynamic properties were evaluated in 61 paediatric patients treated with 1 mg/ kg IV dose of Zenapax every 14 days for a total of 5 doses.
Farmakokineetilisi ja farmakodünaamilisi omadusi uuriti 61 lapsel, keda raviti Zenapax´iga annuses 1 mg/ kg veeni igal 14- ndal päeval, kokku viis annust.